Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 13;8(1):162.
doi: 10.1038/s41392-023-01418-3.

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Affiliations

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Weifeng Liang et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
NSP5 repressed RLR-IFN pathway by affecting the translation. Immunoblotting analysis of p-STAT1, STAT1 when cells were transfected with MDA5 (a), RIG-I (b), MAVS (c), TBK1(d), and IRF3 (e) along with either NSP5 or NSP5 (C145A). Oligomerized MAVS (aggregates) was analyzed by SDD-AGE. Strep-tag (in the control vector, NSP5 or NSP5 (C145A)) was measured to ensure their proper expressions. β-actin was used as a loading control. Cells were transfected with MAVS (f) or TBK1 (g) along with NSP5 or NSP5 (C145A). Total RNA was extracted and analyzed by RT-qPCR with primers specific for IFNβ and ISG15. *: P < 0.05. ns no significance. n = 4. h Immunoblotting analysis of ectopically expressed protein level of MDA5, RIG-I, MAVS, TBK1, IRF3 and STAT1 in 293 T cells along with NSP5 or NSP5 (C145A). i 293 T whole cell extracts (WCEs) were incubated with purified NSP5 at RT for 1 h. Since endogenous MDA5, RIG-I and IFN receptor were low, WCE from FLAG-MDA5, FLAG-RIG-I and IFNαR1 + R2 transfected cells were used. MDA5, RIG-I, MAVS, TBK1, IRF3, STAT1 and IFN-α/βRα were analyzed by immunoblotting. His-tag linked control peptides were spiked in as an internal control. j Fluorescence images of 293 T cells transfected with GFP along with NSP5 or NSP5 (C145A). Scale bar = 100 μm. k A quantification of GFP fluorescence intensity (Excitation 485 nm, Emission 535 nm). l Immunoblotting analysis of GFP expression in the cells transfected with GFP along with NSP5 or NSP5 (C145A). m WCE of cells transfected with GFP was incubated with purified NSP5. His-tag linked control peptides were spiked in as an internal control. n qPCR measurement of GFP RNA in the cells co-transfected with NSP5 or NSP5 (C145A). SUnSET analysis of newly synthesized GFP (o) and MAVS (p). IgL Light chain of IgG. q qPCR measurement of MAVS RNA in the cells co-transfected with vector only (V), NSP5 or NSP5 (C145A). r A screen identified endogenous translation initiation factors that were targeted by an overexpressed NSP5 in 293 T cells. Immunoblotting analysis of translation initiation factors in 293 T cells (s) or in HACEs’ whole cell extracts (t) cleaved by purified NSP5. u Cells were transfected with MAVS, NSP5, PRDIII-Luc, Renilla-Luc and an increasing amount of eIF4G. A dual luciferase assay was performed. v Cells were transfected with MAVS, NSP5, and an increasing amount of eIF4G. Total cellular protein was collected and p-STAT1 was analyzed by immunoblotting analysis. w Immunoblotting analysis of NSP5, eIF4G in HAECs infected with SARS-CoV-2 (MOI = 1)

References

    1. Wu J, et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 2021;34:108761. doi: 10.1016/j.celrep.2021.108761. - DOI - PMC - PubMed
    1. Bastard P, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585. - DOI - PMC - PubMed
    1. Zhang Q, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570. - DOI - PMC - PubMed
    1. Lokugamage KG, et al. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. J. Virol. 2020;94:e01410–e01420. doi: 10.1128/JVI.01410-20. - DOI - PMC - PubMed
    1. Liu Y, et al. SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS to evade the innate immune response. mBio. 2021;12:e02335–02321. doi: 10.1128/mBio.02335-21. - DOI - PMC - PubMed

Publication types

Substances